BUSINESS● LOWSep 22 · Sep 22, 2026, 9:00 AM
Novo CEO signals M&A opportunities to strengthen drug pipeline
CNBC · global
Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS7m agoZedge Q4 2026 Earnings PreviewSeeking Alpha TechBUSINESS7m agoH2O Q3 2026 Earnings PreviewSeeking Alpha Tech